41 results
8-K
EX-10.3
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.2
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
8-K
EX-10.1
iy3k1 agdpgdb5nxpr
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.2
dey5ar7proy
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.1
71h690c
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.3
odwamakwqc1 s03
26 Jan 23
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering
4:02pm
8-K
EX-10.1
1f9rwr 1ahn0g4bak1
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
8-K
EX-10.1
215vi7kpi 2wuk
16 May 22
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.1
pivd 9jipjlfu8u
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-10.3
b1lrlwap
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-10.2
id8xuv em
8 Mar 22
Departure of Directors or Certain Officers
4:38pm
S-1
EX-10.9
8eabllk
23 Jul 20
IPO registration
12:28pm